央视网消息：秋季是易过敏的季节，很多人担心服用抗过敏药会上瘾，所以不敢长期使用，那么到底抗过敏药会不会导致上瘾 呢？ 北京大学第三医院药学部副主任药师 李潇潇：其实我们现在市场上主流的抗过敏药是有两类：第一类是（第二代）抗组胺的这 些药，包括我们平时非常熟西替利嗪、氯雷他定，这个药本身不作于我们的中枢神经系统；第二类药是我们平常会使用的一些鼻喷 的激素，那么这些激素它也是作用于局部，不进入到我们全身的循环，更加不会作用于我们的中枢神经系统。所以这类的药总体来 说都是非常安全的。 专家表示，现在使用的抗过敏药物，如抗组胺药、鼻用激素，并不会让人产生成瘾性。因此，过敏患者用药期间需避免自行停 药，以防导致过敏症状反复或加重。 不过，部分抗组胺药可能导致嗜睡、注意力不集中等问题，从事高空作业、驾驶车辆等需要高度集中注意力工作的人群使用 时，需特别注意用药安全。 ...

碰就炸" : 当你拍打、碾压它时,它会瞬间释放出强酸性毒液 ( pH值1-2, 堪比浓硫酸 )。 "延迟伤害" : 隐翔中出没, 这份防护指南请收好 最近,山东不少朋友都在家里发现了一种 "不速之客" -- 隐翅虫。别看它个头小,威 力可不小,已经有人中招了。秋高气爽,蚊虫 活跃,这份《隐翅虫安全手册》请务必收好。 认识一下，这位"元凶" 外形特征:隐翅虫体长0.6-0.8厘米,形似大蚂蚁, 头腹黑色、前胸和足呈橘黄色,翅膀不明显。 载 2 · 腹部能自由活动 ·前胸背板 ·触角 ·小盾片 · (-10) · 唇狮 ·复眼 生活习性:喜光喜潮,常栖息在水田、草地及树 林中,常在晚上飞入有灯火的地方。所以,热爱 户外,习惯开灯开窗的朋友,要格外留意。 它的武器不是嘴, 是"强酸" 不咬人,不暂人 毒液沾上皮肤后,不会立刻有感觉。但真正的考验 在后面: 第1天:皮肤出现红斑、灼热感。 第2天：红肿加重，开始有明显的灼痛，可能出现水疱。 第3天:可能出现黄色脓疱,痒痛难忍。 这就是传说中的"隐翅虫皮炎" 教科书式操作: 如何赶走它 如果隐翅虫落在了你身上,请默念四字口诀: "吹、弹、别拍"。 错误示范: =掌拍下: ...

Core Viewpoint - The article discusses the increasing prevalence and severity of pollen allergies in northern China during the autumn season, highlighting the differences between autumn and spring allergies, and providing recommendations for prevention and management. Group 1: Autumn Pollen Allergies - Autumn pollen is more allergenic compared to spring pollen, primarily due to the smaller and drier particles from weeds such as ragweed, which can trigger severe allergic reactions even in small amounts [2][4] - The autumn pollen season lasts for 3 to 4 months, making it a prolonged period of potential allergic reactions [2] Group 2: Contributing Factors - Increased mold growth during autumn due to moisture from morning dew and decaying vegetation can also lead to allergic reactions [3] - The dry climate and strong UV radiation in autumn can exacerbate skin conditions and indoor allergies due to dust mites and pet dander [4] Group 3: Prevention and Management - Outdoor protection strategies include avoiding high pollen times, such as windy days and midday hours, and wearing protective eyewear and masks [5][6] - Indoor air purification and humidity control are recommended, including using HEPA filters and maintaining humidity below 50% [8][9] - Medication should be started a week before the pollen season, with common treatments including nasal sprays and oral antihistamines [11][12]

Group 1 - The article addresses common health misconceptions, particularly regarding hair washing and its relation to hair loss, emphasizing that frequent washing does not cause hair loss but rather helps maintain scalp health [4][5]. - It highlights the importance of using antihistamines correctly for allergy management, clarifying that these medications do not lead to dependency [3]. - The article discusses the potential risks of excessive sun protection, warning against overuse of high-SPF products that can damage the skin barrier and lead to other health issues [6][7]. Group 2 - The article explains that using stainless steel water bottles is safe, as long as they meet food safety standards, and debunks the myth that they release harmful levels of manganese [8][9]. - It clarifies that drinking water with mineral deposits (water scale) does not cause kidney stones, attributing such health issues to dietary habits and metabolic factors instead [12]. - The article warns against consuming fruit with mold by simply cutting away the affected parts, as this can still lead to exposure to harmful mycotoxins [13].

Group 1 - The claim that drinking hard water leads to kidney stones is a misconception; hard water is defined by its high mineral content, particularly calcium and magnesium, and does not directly cause kidney stones in healthy individuals [2][4] - Drinking insufficient water can concentrate urine, increasing the risk of urinary system stones, rather than the hardness of the water itself [4] Group 2 - Frequent hair washing does not cause hair loss; the shedding observed during washing is a natural process, as hair naturally falls out during its resting phase [5][7] - The primary factors influencing hair loss are related to immune response, genetics, hormone levels, stress, nutrition, and certain medications, rather than washing frequency [7] Group 3 - The belief that wounds must be disinfected with alcohol is a misconception; while alcohol is a common disinfectant, iodine-based solutions are often recommended for wound care due to their effectiveness and lower skin irritation [8][10] - Alcohol can damage healthy tissue around wounds, potentially hindering healing and leading to scarring [10] Group 4 - The notion that antihistamines can lead to dependency is incorrect; these medications are safe and effective without causing physical or psychological dependence [11][13] - Antihistamines work by blocking histamine receptors to alleviate allergy symptoms, and stopping their use does not result in withdrawal symptoms [13]

Core Viewpoint - The article highlights the urgent demand for effective allergy treatments in China, driven by a significant increase in allergy cases and the corresponding rise in medication sales, indicating a burgeoning market opportunity for pharmaceutical companies [3][8][9]. Market Dynamics - The pollen concentration in Beijing has surged, leading to a 40% year-on-year increase in allergy medication purchases, with specific orders for nasal allergy medications rising by 160% [8]. - The allergy medication market in China, currently valued at a low penetration compared to global standards, is projected to exceed $20 billion by 2030 due to increasing patient awareness and payment capabilities [8][9]. Product Trends - Traditional allergy medications like Loratadine have seen a significant sales increase, with total retail sales surpassing 7.6 billion yuan in the past five years, maintaining an annual growth rate of over 10% [11][13]. - New formulations and delivery methods, such as oral liquids and syrups, are being explored by pharmaceutical companies to enhance market competitiveness [11]. Innovation in Allergy Treatments - The introduction of innovative biologics, such as Dupilumab, which targets IL-4Rα, marks a significant advancement in allergy treatment, showing promising clinical results in alleviating symptoms [17]. - The global clinical trial landscape for allergy treatments has expanded, with over 1,600 studies registered, indicating a strong focus on developing new therapies [14]. Pricing and Market Challenges - Biologics, while effective, come with high price points, which may deter patients who prefer cost-effective options. Balancing efficacy and affordability remains a challenge for companies in this sector [19][20]. - Desensitization therapy, although lengthy, is viewed as a potential long-term solution for allergy sufferers, with companies like Iwubio reporting significant sales growth in their desensitization products [21]. Future Outlook - The allergy medication market is poised for growth, with numerous companies entering the space, seeking to capitalize on the increasing demand for effective treatments [21].

Core Viewpoint - The article discusses the significant increase in pollen levels in Beijing due to a warm winter, leading to a surge in allergy cases and a corresponding rise in the demand for allergy medications, indicating a booming market for allergy-related pharmaceuticals [1][8][9]. Industry Overview - The allergy medication market in China is projected to experience rapid growth, potentially exceeding $20 billion by 2030, driven by an increasing patient population and rising awareness of allergy conditions [8][9]. - Currently, there are approximately 500 million patients in China suffering from allergic diseases such as allergic rhinitis, asthma, atopic dermatitis, and chronic obstructive pulmonary disease [8]. Market Dynamics - Recent data shows a 40% year-on-year increase in the purchase of allergy-related medications, with a 127% day-on-day increase in orders since March 20 in Beijing [8]. - Popular allergy medications like Loratadine and its upgraded version Desloratadine have seen significant sales growth, with Loratadine's retail market sales surpassing 7.6 billion yuan in the past five years, maintaining an annual growth rate of over 10% [10][11]. Competitive Landscape - The allergy medication market is characterized by numerous players, primarily traditional pharmaceutical companies that have historically relied on generic drugs [10]. - New entrants are focusing on innovative drug development, including small molecule targeted drugs and biological agents, with over 1,600 clinical trials related to allergies registered globally [12][13]. Emerging Trends - A new biological drug, Dupilumab, has been approved for treating seasonal allergic rhinitis, showing promising results in clinical trials [13]. - The high pricing of biological drugs presents a challenge for patient acceptance, as many patients prefer cost-effective options despite the superior efficacy of these new treatments [15]. Treatment Innovations - Desensitization therapy is gaining attention as a long-term solution for allergies, although it requires a lengthy treatment period [16][17]. - Companies like Iwubio are already seeing sales growth in desensitization products, indicating a potential shift in treatment preferences among patients [17]. Future Outlook - The allergy medication market in China is still in its early stages, with many companies vying for a share of this lucrative sector, awaiting the emergence of the next blockbuster product [19].